• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国镰状细胞病患儿隐匿性高血压患病率无增加。

No Increase in Masked Hypertension Prevalence in Children With Sickle Cell Disease in France.

作者信息

Bokov Plamen, Koehl Berengere, Benzouid Chérine, Verlhac Suzanne, Missud Florence, Benkerrou Malika, Delclaux Christophe

机构信息

Paris University, AP-HP, Robert Debré Hospital, Department of Physiology, INSERM NeuroDiderot, Paris, France.

Department of Hematology, Paris University, AP-HP, Robert Debré Hospital, Sickle Cell Disease Center, Hematology Unit, Paris, France.

出版信息

Am J Hypertens. 2024 Apr 15;37(5):358-365. doi: 10.1093/ajh/hpae013.

DOI:10.1093/ajh/hpae013
PMID:38323455
Abstract

BACKGROUND

An important prevalence (32%-45%) of masked hypertension has been reported in children with sickle cell disease (SCD). Stroke screening is well established using transcranial Doppler (TCD) ultrasound. The objectives of our proof-of-concept study in childhood SCD were to evaluate the prevalence of hypertension and its relationships with cerebral vasculopathy (TCD velocity) and to further evaluate in a subgroup of children the correlations of cardiovascular autonomic nervous system indices with TCD velocity.

METHODS

Ambulatory blood pressure measurement (ABPM) and TCD velocity were obtained in children with SCD and in a restricted sample, cardiac sympathovagal balance using heart rate variability analyses, baroreflex sensitivity, and pulse wave velocity were measured.

RESULTS

In 41 children with SCD (median age 14.0 years, 19 girls, SS/Sβ + thalassemia/SC: 33/2/6), ABPM results showed masked hypertension in 2/41 (5%, 95% confidence interval, 0-11) children, consistent with the prevalence in the general pediatric population, elevated blood pressure (BP) in 4/41 (10%) children, and a lack of a normal nocturnal dip in 19/41 children (46%). Children with increased TCD velocity had lower nocturnal dipping of systolic BP. In the 10 participants with extensive cardiovascular assessment, increased TCD velocity was associated with parasympathetic withdrawal and baroreflex failure. Exaggerated orthostatic pressor response or orthostatic hypertension was observed in 7/10 children that was linked to parasympathetic withdrawal.

CONCLUSIONS

Autonomic nervous system dysfunction, namely loss of parasympathetic modulation, of SCD contributes to increase TCD velocity but is not associated with an increased prevalence of masked hypertension.

CLINICAL TRIALS REGISTRATION

NCT04911049.

摘要

背景

据报道,镰状细胞病(SCD)患儿中隐匿性高血压的患病率较高(32%-45%)。经颅多普勒(TCD)超声检查已广泛用于中风筛查。我们在儿童SCD中进行的概念验证研究的目的是评估高血压的患病率及其与脑血管病变(TCD速度)的关系,并在一组儿童亚组中进一步评估心血管自主神经系统指标与TCD速度的相关性。

方法

对SCD患儿进行动态血压测量(ABPM)和TCD速度测量,并在一个受限样本中,使用心率变异性分析、压力反射敏感性和脉搏波速度测量心脏交感迷走神经平衡。

结果

在41例SCD患儿(中位年龄14.0岁,19名女孩,SS/Sβ+地中海贫血/SC:33/2/6)中,ABPM结果显示2/41(5%,95%置信区间,0-11)例患儿存在隐匿性高血压,与普通儿科人群的患病率一致,4/41(10%)例患儿血压升高,19/41例患儿(46%)夜间血压缺乏正常下降。TCD速度增加的患儿夜间收缩压下降幅度较小。在10名进行广泛心血管评估的参与者中,TCD速度增加与副交感神经活动减弱和压力反射功能衰竭有关。7/10例患儿出现过度的直立性升压反应或直立性高血压,这与副交感神经活动减弱有关。

结论

SCD的自主神经系统功能障碍,即副交感神经调节丧失,会导致TCD速度增加,但与隐匿性高血压患病率增加无关。

临床试验注册

NCT04911049。

相似文献

1
No Increase in Masked Hypertension Prevalence in Children With Sickle Cell Disease in France.法国镰状细胞病患儿隐匿性高血压患病率无增加。
Am J Hypertens. 2024 Apr 15;37(5):358-365. doi: 10.1093/ajh/hpae013.
2
The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.儿童镰状细胞病的一级卒中预防的临床效果和成本效益:系统评价和经济评估。
Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430.
3
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.镰状细胞病患者无症状性脑梗死的预防干预措施。
Cochrane Database Syst Rev. 2017 May 13;5(5):CD012389. doi: 10.1002/14651858.CD012389.pub2.
4
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
5
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
6
Optimizing Transcranial Doppler Screening for Stroke Prevention in Young African Children With Sickle Cell Disease.优化经颅多普勒超声筛查以预防患有镰状细胞病的非洲幼儿中风
Pediatr Blood Cancer. 2025 Sep;72(9):e31861. doi: 10.1002/pbc.31861. Epub 2025 Jun 24.
7
Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.儿童隐匿性高血压的患病率及亚临床心血管结局风险:系统评价和荟萃分析。
Hypertension. 2023 Nov;80(11):2280-2292. doi: 10.1161/HYPERTENSIONAHA.123.20967. Epub 2023 Sep 22.
8
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD003146. doi: 10.1002/14651858.CD003146.pub3.
9
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟基脲素)用于镰状细胞病。
Cochrane Database Syst Rev. 2017 Apr 20;4(4):CD002202. doi: 10.1002/14651858.CD002202.pub2.
10
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.